Induction of Immunotolerance in Rats by Intratesticular Administration of an Eicosapeptide of Bovine S-Antigen

References

• Nussenblatt R. B., Caspi R. R., Mahdi R., Chan C. C., Roberge F., Lider O., Weiner H. L. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen. J. Immunol. 1990; 144: 1689–1695
   PubMed Web of Science ®Google Scholar
• Weiner H. L., Friedman A., Miller A., Khoury S. J., Al-Sabbagh A., Santos L., Sayegh M., Nussenblatt R. B., Trentham D. E., Hafler D. A. Oral tolerance: Immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Ann. Rev. Immunol. 1994; 12: 809–837
   PubMed Web of Science ®Google Scholar
• Mizuno K., Clark A. F., Streilein J. W. Ocular injection of retinal S-antigen: Suppression of autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 1989; 30: 772–774
   PubMedGoogle Scholar
• Streilein J. W., Wilbanks G. A., Cousins S. W. Immuno-regulatory mechanisms of the eye. J. Neuroimmunol. 1992; 39: 185–200
   PubMedGoogle Scholar
• Peng B., Yoshitoshi T., Shichi H. Suppression of experimental autoimmune uveoretinitis by intra-orchidic administration of S-antigen. Autoimmunity 1992; 14: 149–153
   PubMed Web of Science ®Google Scholar
• Ren J., Singh A. K., Shichi H. Characteristics of immunotolerance induced by intratesticular injection of S-antigen. Ocular Immunol. Inflam. 1995; 3: 129–137
   PubMedGoogle Scholar
• Ren J., Shichi H. Induction of immunotolerance by orchidic administration of S-antigen: Suppression of uveitis by cell transfer. Regional Immunol. 1994; 6: 177–180
   Google Scholar
• Suh E. D. W., Vistica B. P., Chan C. C., Raber J. M., Gery I., Nussenblatt R. B. Curr. Eye Res. 1993; 12: 833–839
   PubMed Web of Science ®Google Scholar
• Nussenblatt R. B. Experimental autoimmune uveitis: Mechanisms of disease and clinical therapeutic indications. Invest. Ophthalmol. Vis. Sci. 1991; 32: 3131–3141
   PubMed Web of Science ®Google Scholar
• Chen Y., Kuchroo V. K., Inobe J., Hafler D. A., Weiner H. L. Regulatory T cell clones induced by oral tolerance: Suppression of autoimmune encephalomyelitis. Science 1994; 265: 1237–1240
   PubMed Web of Science ®Google Scholar
• Wilbanks A., Streilein J. W. Characterization of suppressor cells in anterior chamber-associated immune deviation (ACAID) induced by soluble antigen. Evidence of two functionally and phenotypically distinct T-cell suppressor populations. Immunol. 1990; 71: 383–389
   PubMed Web of Science ®Google Scholar
• Gregerson D. S., Obritish W. F., Donoso L. A. Oral tolerance in experimental autoimmune uveitis: Distinct mechanisms of resistance are induced by low dose versus high dose feeding protocols. J. Immunol. 1993; 151: 5751–5761
   PubMed Web of Science ®Google Scholar
• Friedman A., Weiner H. L. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. USA 1994; 91: 6688–6692
   PubMed Web of Science ®Google Scholar
• Caspi R. R. Th1 and Th2 lymphocytes in experimental autoimmune uveoretinitis. Advances in Ocular Immunology, R. B. Nussenblatt, S. M. Whitcup, R. R. Caspi, I Gery. Elsevier Science, Amsterdam 1994; 55–58
   Google Scholar
• Gery I., Mochizuki M., Nussenblatt R. B. Retinal specific antigens and immunopathogenic processes they provoke. Progress in Retinal Research, N. Osborne, J. Chader. Pergamon Press, Oxford and New York 1986; Vol. 5: 74–109
   Google Scholar
• McMenamin P. G., Forrester J. T., Steptoe R., Dua H. S. Ultrastructural pathology of experimental autoimmune uveitis in the rat. Autoimmunity 1993; 16: 83–93
   PubMed Web of Science ®Google Scholar
• Donoso L. A., Merryman C. F., Sery T. W., Shinohara T., Dielzschold B., Smith A., Kalsow C. M. S-antigen characterization of a pathogenic epitope which mediates experimental uveitis and pinealitis in Lewis rats. Cure Eye Res. 1987; 6: 1151–1159
   PubMed Web of Science ®Google Scholar
• Gregerson D. S., Merryman C. F., Obritsch W. F., Donoso L. A. Identification of a new pathogenic site in human retinal S-antigen which induces experimental autoimmune uveoretinitis in LEW rats. Cell Immunol. 1990; 128: 209–219
   PubMed Web of Science ®Google Scholar
• Merryman C. F., Donoso L. A., Zhang X., Heber-Katz E., Gregerson D. S. Characterization of a new potent immunopathogenic epitopes in S-antigen which elicits T cells expressing Vβ8 and Vα2 genes. J. Immunol. 1991; 146: 75–80
   PubMed Web of Science ®Google Scholar
• Fling S. P., Donoso L. A., Gregerson D. S. In vitro unresponsiveness to autologous sequences of the immunopathogenic autoantigen, S-antigen. J. Immunol. 1991; 147: 483–489
   PubMed Web of Science ®Google Scholar
• Thurau S. R., Chan C. C., Suh E., Nussenblatt R. B. Induction of oral tolerance to S-antigen induced experimental autoimmune uveitis by a uveitogenic 20 mer peptide. J. Autoimmun. 1991; 4: 507–516
   PubMed Web of Science ®Google Scholar
• Vrabec T. R., Gregerson D. S., Dua H. S., Donoso L. A. Inhibition of experimental autoimmune uveoretinitis by oral administration of S-antigen and synthetic peptides. Autoimmunity 1992; 12: 175–184
   PubMed Web of Science ®Google Scholar
• Gregerson D. S., Obritisch W. F., Donoso L. A. Oral tolerance in experimental autoimmune uveoretinitis. J. Immunol. 1993; 151: 5751–5761
   PubMed Web of Science ®Google Scholar
• Cserr H. F., Knopf P. M. Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view. Immunol. Today 1992; 13: 507–512
   PubMedGoogle Scholar
• Dick A. D., Cheng Y. F., Liversidge J., Forrester J. V. Intranasal administration of retinal antigens suppresses retinal antigen-induced experimental autoimmune uveoretinitis. Immunol. 1994; 82: 625–631
   PubMed Web of Science ®Google Scholar
• Bellgrau D., Gold D., Selawry H., Moore J., Franzusoff A., Duke R. C. A role for CD95 ligand in preventing graft rejection. Nature 1995; 377: 630–632
   PubMed Web of Science ®Google Scholar
• Griffith T. S., Brunner T., Fletcher S. M., Green D. R., Ferguson T. A. Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 1995; 270: 1189–1192
   PubMed Web of Science ®Google Scholar
• Das N. D., Ulshafer R. F., Zam Z. S., Leverenz V. R., Shichi H. Radioimmunocytochemical localization of retinal S-antigen with monoclonal antibodies. J. Histochem. Cytochem. 1984; 32: 834–838
   PubMed Web of Science ®Google Scholar
• Tuyen V. V., Faure J. P., Thillaye B., DeKozak Y., Fortier B. Antibody determination by ELISA in rats with retinal S-antigen-induced uveoretinitis. Curr. Eye Res. 1982/1983; 2: 7–12
   PubMed Web of Science ®Google Scholar
• Ren J., Shichi H. Phenotype of suppressor cells induced by orchidic injection of S-antigen (S-Ag). Advances in Ocular Immunology, R. B. Nussenblatt, S. M. Whitcup, R. R. Caspi, I. Gery. Elsevier Science, Amsterdam 1994; 203–206
   Google Scholar
• Saoudi A., Kuhn J., Huygen K., DeKozak Y., Velu T., Goldman M., Druet P., Bellon B. TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease. Eur. J. Immunol. 1993; 23: 3096–3103
   PubMed Web of Science ®Google Scholar
• Shichi H., Mahalak S. M., Sakamoto S., Lin W. L., Essner E. S. Immunocytochemical localization of gamma-glutamyl transpeptidase in porcine ciliary epithelium. Exp. Eye Res. 1991; 53: 39–46
   PubMedGoogle Scholar
• Hara Y., Caspi R. R., Wiggert B., Chan C. C., Wilbanks G. A., Streilein J. W. Suppression of experimental autoimmune uveitis in mice by induction of anterior chamber-associated immune deviation with interphotoreceptor retinoid-binding protein. J. Immunol. 1992; 148: 1685–1692
   PubMed Web of Science ®Google Scholar
• Metzler B., Wraith D. C. Inhibition of experimental autoimmune encephalomyelitis by inhalation but not oral administration of the encephalitogenic peptide: influence of MHC binding affinity. Int. Immunol. 1993; 5: 1159–1165
   PubMed Web of Science ®Google Scholar
• Miller A., Hafler D. A., Weiner H. L. Tolerance and suppressor mechanisms in experimental autoimmune encephalomyelitis: implications for immunotherapy of human autoimmune diseases. FASEB J. 1991; 5: 2560–2566
   PubMed Web of Science ®Google Scholar
• Whitacre C. C., Gienapp I. E., Orosz C. G., Bitar D. Oral tolerance in experimental autoimmune encephalomyelitis. III. Evidence for clonal anergy. J. Immunol. 1991; 147: 2155–2163
   PubMed Web of Science ®Google Scholar
• Friedman A., Weiner H. L. Induction of anergy or active suppression following oral tolerance is determined by antigen dosage. Proc. Natl. Acad. Sci. USA 1994; 91: 6688–6692
   PubMed Web of Science ®Google Scholar
• Arnon R., Teitelbaum D. On the existence of suppressor cells. Intl. Arch. Alergy Immunol. 1993; 100: 2–7
   Google Scholar
• Chen Y., Inobe J., Weiner H. Induction of oral tolerance to myelin basic protein in CD8-depleted mice: Both CD4+ and CD8+ cells mediate active suppression. J. Immunol. 1995; 155: 910–916
   Google Scholar